Sebastian Salas-Vega
Dados Biográficos
| ID | 2204292 |
|---|---|
| NOME | Sebastian Salas-Vega |
| PRENOMES | Sebastian |
| SOBRENOME | Salas-Vega |
| ASSINATURA | SALAS-VEGA S |
| ORCID | 0000-0003-3888-7113 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2020 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2020 |
| ÍNDICE H | 0 |
Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US
As cancer drug prices rise, it remains unclear whether the cost of new interventions is related to their beneficial impact for patients at a societal-level. Using data for 2003-2015 from the IQVIA MIDAS(R) dataset, the relationship between cancer drug costs and drug clinical benefits was studied in four countries with different approaches to drug pricing. Summary measures of drug clinical effects on overall survival, quality of life, and safety w…
Sem obras proeminentes nesta página.
Relationship between costs and clinical benefits of new cancer medicines in Australia, France, the UK, and the US
As cancer drug prices rise, it remains unclear whether the cost of new interventions is related to their beneficial impact for patients at a societal-level. Using data for 2003-2015 from the IQVIA MIDAS(R) dataset, the relationship between cancer drug costs and drug clinical benefits was studied in four countries with different approaches to drug pricing. Summary measures of drug clinical effects on overall survival, quality of life, and safety w…
Cancer (1 obras) · Cancer drugs (1 obras) · Drug (1 obras) · Economic and Financial Impacts of Cancer (1 obras) · Environmental health (1 obras) · Health economics (1 obras) · Health Systems, Economic Evaluations, Quality of Life (1 obras) · Internal Medicine (1 obras) · Medicine (1 obras) · Nursing (1 obras)